Sort
82,697 grants matching “vaccine development”
Longitudinal Analysis of Immune Signatures (IMS) of M. tuberculosis-specific T cells
$1,069,073Bjoern Peters · La Jolla Institute For Immunology · U19 · FY2024 · AI
Global Identification of Dengue Virus Epitopes Following Exposure, Vaccination, and Acute Infection
$1,069,016Alex Sette · La Jolla Institute For Immunology · N01 · FY2018 · AI
A STINGing vaccine for TB
$1,068,965William Ramses Bishai · Johns Hopkins University · R01 · FY2024 · AI
Development Research Plan
$1,068,870Ashlee V Moses · Oregon Health & Science University · U54 · FY2012 · AI
Vector-Borne Diseases: Biology Of Vector Host Relationship
$1,068,794Jose Ribeiro · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
High throughput NAPPA-proteoimmunomics and Vibrio cholerae vaccine development
$1,068,774Edward T. Ryan · Massachusetts General Hospital · U01 · FY2009 · AI
Task C08: Vaccine Testing in Monkeypox NHP Model
$1,068,747Mary Bruce · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2011 · AI
The Empilisweni Center for Women's Health - Advancing Implementation of Equitable Cervical Cancer Control
$1,068,363Delivette Castor · Columbia University Health Sciences · U54 · FY2024 · CA
COBRE for Perinatal Biology
$1,068,127James F Padbury · Women And Infants Hospital-Rhode Island · P30 · FY2015 · GM
Control Systems Governing Short vs Longterm Humoral & Cellular Immunity
$1,068,125Christopher C Goodnow · Scripps Research Institute, The · U19 · FY2014 · AI
Discovery and Translational Core Services
$1,068,010Gerald A Beltz · Harvard Medical School · U19 · FY2014 · AI
Discovering mechanisms of neuroblastoma tumorigenesis to improve patient outcomes
$1,068,000John M Maris · Children'S Hosp Of Philadelphia · R35 · FY2025 · CA
Development of a novel adjuvanted Th1- and Th17-inducing subunit TB Vaccine
$1,067,980Shabaana A. Khader · University Of Chicago · R33 · FY2025 · AI
Monoclonal Antibodies in Biodefense: Ebola Viruses
$1,067,924Larry Zeitlin · Mapp Biopharmaceutical, Inc. · U01 · FY2006 · AI
Advanced Mass Spectrometry Facility
$1,067,912David Anderson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2010 · DK
Optimization and preclinical development of a TB Multiple Antigen Presenting System (MAPS) vaccine
$1,067,677Richard Malley · Boston Children'S Hospital · R01 · FY2020 · AI
Ontogeny &Maintenance of Virus Specific T Cells
$1,067,647Univ Of Massachusetts Med Sch Worcester · P01 · FY2004 · AI
Vaccines and Therapeutics for Nipah and Hendra virus
$1,067,628Christopher Broder · Henry M. Jackson Fdn For The Adv Mil/Med · U01 · FY2011 · AI
Immune Reconstitution
$1,067,628Ronald Gress · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Antidotes to Anthrax Lethal Factor Intoxication
$1,067,549Alan Thomas Johnson · Panthera Biopharma, Llc · U01 · FY2009 · AI
Development of an anti-malaria toxin vaccine candidate
$1,067,392William J Christ · Ancora Pharmaceuticals, Inc. · R44 · FY2006 · AI
Medical Scientist Training Program
$1,067,310Terence S. Dermody · Vanderbilt University · T32 · FY2009 · GM
Molecular Dynamics Simulations Of Biological Macromolecules
$1,067,238Bernard R Brooks · National Heart, Lung, And Blood Institute · ZIA · FY2020 · HL
Development of an anti-malaria toxin vaccine candidate
$1,066,844Ancora Pharmaceuticals, Inc. · R44 · FY2005 · AI
Structure-Based Design of Drugs and Vaccines for Target*
$1,066,816Edward V Arnold · Rutgers, The State Univ Of N.J. · P01 · FY2006 · GM